![An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The](https://jcadonline.com/wp-content/uploads/September2020PanchaprateepFigure2.jpg)
An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The
![Hair global photographs of LLLT group (a), minoxidil group (b), and the... | Download Scientific Diagram Hair global photographs of LLLT group (a), minoxidil group (b), and the... | Download Scientific Diagram](https://www.researchgate.net/publication/346058543/figure/fig1/AS:960344356843522@1605975345175/Hair-global-photographs-of-LLLT-group-a-minoxidil-group-b-and-the-combined-group.png)
Hair global photographs of LLLT group (a), minoxidil group (b), and the... | Download Scientific Diagram
![An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The](https://jcadonline.com/wp-content/uploads/September2020PanchaprateepFigure1.jpg)
An Herbal Extract Combination (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) versus 3% Minoxidil Solution for the Treatment of Androgenetic Alopecia: A 24-week, Prospective, Randomized, Triple-blind, Controlled Trial – JCAD | The
![Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research](https://onlinelibrary.wiley.com/cms/asset/5134f214-c1ef-45f6-9e48-7b707e9c328b/srt12827-fig-0001-m.jpg)
Placebo‐controlled dose‐effect studies with topical minoxidil 2% or 5% in male‐patterned hair loss treated with oral finasteride employing an analytical and exhaustive study protocol - Van Neste - 2020 - Skin Research
![Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs41702-019-0046-y/MediaObjects/41702_2019_46_Fig2_HTML.png)
Trichogenic effect of topical ketoconazole versus minoxidil 2% in female pattern hair loss: a clinical and trichoscopic evaluation | Biomedical Dermatology | Full Text
![Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial Gajjar PC, Mehta HH, Barvaliya M, Sonagra B - Int J Trichol Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial Gajjar PC, Mehta HH, Barvaliya M, Sonagra B - Int J Trichol](https://www.ijtrichology.com/articles/2019/11/2/images/IntJTrichol_2019_11_2_58_255705_f8.jpg)
Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male: A randomized controlled trial Gajjar PC, Mehta HH, Barvaliya M, Sonagra B - Int J Trichol
![Representative photographs of four patients treated with PRGF (a, b) or... | Download Scientific Diagram Representative photographs of four patients treated with PRGF (a, b) or... | Download Scientific Diagram](https://www.researchgate.net/publication/289504311/figure/fig4/AS:960050260627459@1605905227036/Representative-photographs-of-four-patients-treated-with-PRGF-a-b-or-topical-minoxidil.gif)
Representative photographs of four patients treated with PRGF (a, b) or... | Download Scientific Diagram
![A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R - Int A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R - Int](https://www.ijtrichology.com/articles/2019/11/2/images/IntJTrichol_2019_11_2_68_255701_f10.jpg)
A study to compare the efficacy of platelet-rich plasma and minoxidil therapy for the treatment of androgenetic alopecia Verma K, Tegta GR, Verma G, Gupta M, Negi A, Sharma R - Int
![PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation” PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”](https://i1.rgstatic.net/publication/335764203_Reply_to_Very-low-dose_oral_minoxidil_in_male_androgenetic_alopecia_A_study_with_quantitative_trichoscopic_documentation/links/5e6e6acb92851c6ba706407c/largepreview.png)
PDF) Reply to: “Very-low-dose oral minoxidil in male androgenetic alopecia: A study with quantitative trichoscopic documentation”
![Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13555-020-00448-x/MediaObjects/13555_2020_448_Fig1_HTML.jpg)
Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment | SpringerLink
![PDF] Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride | Semantic Scholar PDF] Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/687d6bdc19d46334d49d1044ac3457ab60dedac9/3-Figure3-1.png)
PDF] Topical minoxidil fortified with finasteride: An account of maintenance of hair density after replacing oral finasteride | Semantic Scholar
![A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia | Semantic Scholar A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7750fbdf4bef17d8aa31dde556311967d74750dd/3-Figure2-1.png)
A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia | Semantic Scholar
![Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology Effectiveness and safety of low-dose oral minoxidil in male androgenetic alopecia - Journal of the American Academy of Dermatology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6325c11a-9de6-41d6-9c31-91a0016c4c2c/gr1.jpg)